FDA Policy and Cardiovascular Medicine
نویسندگان
چکیده
منابع مشابه
Health Policy and Cardiovascular Medicine
1098 The United States is in the midst of a healthcare crisis. With access that is spotty, quality that is uneven, and care that is often suboptimal, we lag behind other countries in key health metrics such as life expectancy and infant mortality. Furthermore, our healthcare costs are approaching an unsustainable 18% of Gross Domestic Product, and we were recently ranked among the least efficie...
متن کاملHealth Policy and Cardiovascular Medicine
2151 Episode-based, “bundled” payments have come to the forefront of the national discussion on combating rising healthcare costs. In the currently dominant fee-for-service model for reimbursement, hospitals, physicians, and postacute care providers file distinct claims and are paid separately for provided services even when they are related to a single episode of care. However, this approach t...
متن کاملHealth Policy and Cardiovascular Medicine
1136 The US Food and Drug Administration (FDA) is among the oldest agencies in the federal government. Its origins can be traced back to 1862, when President Abraham Lincoln appointed a chemist, Charles M. Wetherill, to serve in the Department of Agriculture. One of the key early pieces of legislation that initiated the evolution of the FDA into its modern form was the 1906 Pure Food and Drug A...
متن کاملHealth Policy in Cardiovascular Medicine
205 Cardiovascular disease is the leading cause of death in the United States and constitutes 17% of overall national health expenditures, with noninvasive testing contributing much of the cost growth in recent years. Cardiovascular medicine has long been at the forefront of evidence-based practice, with arguably the longest-standing and most comprehensive array of efforts to measure risk facto...
متن کاملMicroRNAs and cardiovascular medicine
MicroRNAs are non-coding RNA sequences that act as regulators of gene expression. They are aberrantly expressed in many pathological conditions. Cardiovascular diseases are among the leading causes of morbidity and mortality in the general population. Various knock-in and knockdown approaches have shown abnormal signature patterns of microRNAs in cardiovascular conditions like cardiac hypertrop...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2015
ISSN: 0009-7322,1524-4539
DOI: 10.1161/circulationaha.114.010295